Angela Harmantas

Toronto

Senior Journalist at Proactive Investors

Financial journalist covering rocks and stocks at @proactive_ca @proactive_NA

Featured in: Favicon

proactiveinvestors.com Favicon

proactiveinvestors.co.uk Favicon

ourcommunitynow.com Favicon

proactiveinvestors.com.au

Articles

Standard Uranium deploys ExoSphere Multiphysics surveys at Davidson River

1 week ago | proactiveinvestors.com | Emily Jarvie |Angela Harmantas

MiningUranium This record is published on behalf of Standard Uranium Ltd, a paid client of ProactiveAbout this content Disclaimer No investment advice About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022.
NanoViricides touts antiviral NV-387 as tool against new COVID variant

1 week ago | proactiveinvestors.com | Angela Harmantas

NanoViricides (NYSE-A:NNVC) said its experimental antiviral drug NV-387 could play a role in combating emerging threats from COVID-19 and bird flu, as new virus variants raise global health concerns. The company pointed to the rise of the COVID variant NB.1.8.1, or "Nimbus," which is spreading in the US and globally.
Peru targets long-term mining dominance with copper, silver and zinc projects

1 week ago | proactiveinvestors.com | Emily Jarvie |Angela Harmantas

Peru is ramping up efforts to cement its role as a global mining powerhouse, forecasting $4.8 billion in new investment in 2025 as demand for copper and other critical minerals accelerates. The Energy and Mines Ministry expects output to rise in 2025, as global producers and junior miners double down on one of the world's richest copper reserves. Copper output is expected to rise to 2.8 million metric tons this year.
Lisata Therapeutics to lead development of opioid use disorder drug under expanded alliance

1 week ago | proactiveinvestors.com | Emily Jarvie |Angela Harmantas

Lisata Therapeutics Inc (NASDAQ:LSTA) and GATC Health have expanded their strategic alliance aimed at accelerating and improving the success rate of drug development using artificial intelligence (AI). The expanded collaboration builds on prior work in which GATC provided AI-based analysis supporting Lisata’s certepetide drug candidate.
Gunnison Copper advances high-value programs at Arizona project

1 week ago | proactiveinvestors.com | Angela Harmantas

Mining This record is published on behalf of Gunnison Copper Corp, a paid client of ProactiveAbout this content Disclaimer No investment advice About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks.
Giyani Metals receives preliminary backing from US EXIM for $225M in project financing

1 week ago | proactiveinvestors.com | Angela Harmantas

MiningBattery Metals This record is published on behalf of Giyani Metals Corp, a paid client of ProactiveAbout this content Disclaimer No investment advice About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks.
New Era Helium eyes billion-dollar AI project in Texas

2 weeks ago | proactiveinvestors.com | Angela Harmantas

New Era Helium Inc (NASDAQ:NEHC) CEO Will Gray talked with Proactive about the company's latest developments in Texas, focusing on its pivot into AI infrastructure. Gray explained that New Era Helium originally acquired 235 acres in Ector County, Texas, targeting a powered land or powered shell opportunity aimed at attracting a top-tier hyperscaler to the Permian Basin.
Aftermath Silver CEO on new Peru drill findings – ICYMI

2 weeks ago | proactiveinvestors.com | Angela Harmantas

MiningGold & Silver This record is published on behalf of Aftermath Silver Ltd, a paid client of ProactiveAbout this content Disclaimer No investment advice About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks.
Tiziana expands Phase 2 MS trial to fifth site, commences patient dosing

2 weeks ago | proactiveinvestors.com | Emily Jarvie |Angela Harmantas

HealthPharma & Biotech This record is published on behalf of Tiziana Life Sciences Ltd, a paid client of ProactiveAbout this content Disclaimer No investment advice About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022.
Gold consolidates after record surge, but structural case for equities remains strong

2 weeks ago | proactiveinvestors.com | Angela Harmantas

InsightMining This record is published on behalf of US Gold Corp, a paid client of ProactiveAbout this content Disclaimer No investment advice About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks.